Insider Transactions in Q2 2022 at Avadel Pharmaceuticals PLC (AVDL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Geoffrey Michael Glass Director |
BUY
Open market or private purchase
|
Indirect |
45,000
+50.0%
|
$90,000
$2.14 P/Share
|
|
Jun 01
2022
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
20,000
+12.91%
|
$40,000
$2.27 P/Share
|
|
May 31
2022
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
15,000
+11.55%
|
$30,000
$2.16 P/Share
|
|
May 27
2022
|
Peter J. Thornton Director |
BUY
Open market or private purchase
|
Direct |
50,000
+37.58%
|
$50,000
$1.69 P/Share
|
|
May 27
2022
|
Gregory J Divis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+25.11%
|
$100,000
$2.05 P/Share
|
|
May 27
2022
|
Eric J Ende Director |
BUY
Open market or private purchase
|
Direct |
15,000
+13.05%
|
$30,000
$2.45 P/Share
|
|
May 27
2022
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+41.15%
|
$100,000
$2.14 P/Share
|
|
May 27
2022
|
Linda Palczuk Director |
BUY
Open market or private purchase
|
Direct |
10,000
+17.27%
|
$10,000
$1.6 P/Share
|